MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 240 filers reported holding MEDIVATION INC in Q1 2014. The put-call ratio across all filers is 1.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $37,961,000 | +178.2% | 627,877 | +64.6% | 0.15% | +146.7% |
Q1 2016 | $13,647,000 | -24.9% | 381,530 | +1.5% | 0.06% | -22.1% |
Q4 2015 | $18,170,000 | +22.6% | 375,878 | +7.8% | 0.08% | +18.5% |
Q3 2015 | $14,823,000 | -28.4% | 348,785 | +77.4% | 0.06% | -23.5% |
Q2 2015 | $20,710,000 | +30.2% | 196,621 | +49.3% | 0.08% | +28.8% |
Q1 2015 | $15,906,000 | +49.7% | 131,734 | +23.5% | 0.07% | +37.5% |
Q4 2014 | $10,625,000 | +404.5% | 106,661 | +400.8% | 0.05% | +380.0% |
Q3 2014 | $2,106,000 | +23.8% | 21,300 | -20.1% | 0.01% | +11.1% |
Q4 2013 | $1,701,000 | -48.3% | 26,650 | -51.4% | 0.01% | -50.0% |
Q3 2013 | $3,288,000 | -19.4% | 54,850 | -33.8% | 0.02% | -21.7% |
Q2 2013 | $4,079,000 | – | 82,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |